The first and only blockchain built for finance that is open, interoperable layer-one blockchain powering next-generation finance applications, including DeFi, RWAs, AI, decentralized exchanges, prediction markets, lending protocols, and more, is set for a comeback with a speculated 140% surge in sight.
Weeks after Breaking down from a rising wedge which is a bearish pattern,
INJ has shown signs of a reversal. With the Relative Strength Index (RSI) already oversold at 28
INJ is gearing up for a massive comeback with the All-time high of $52.75 a move to the $19 pivot point could spark the resurgence to the recent ATH attained.
Similarly, with growing momentum and the asset trading below key moving averages (MA)
INJ is currently up by 3.41%. The Injective Protocol is becoming an asset worth watching.
Injective Price Live Data
The live Injective price today is $8.77 USD with a 24-hour trading volume of $166,682,991 USD. Injective is down 7.91% in the last 24 hours, with a live market cap of $867,892,886 USD. It has a circulating supply of 98,970,935 INJ coins and the max. supply is not available.
Weeks after Breaking down from a rising wedge which is a bearish pattern,
Similarly, with growing momentum and the asset trading below key moving averages (MA)
Injective Price Live Data
The live Injective price today is $8.77 USD with a 24-hour trading volume of $166,682,991 USD. Injective is down 7.91% in the last 24 hours, with a live market cap of $867,892,886 USD. It has a circulating supply of 98,970,935 INJ coins and the max. supply is not available.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.